To investigate systematic metabolic biomarkers for early diagnosis of glucose-well-controlled DM patients who still developed diabetic retinopathy (GW-DR) and explore potential biomarker-based precise
Purpose: To reveal molecular mechanisms of diabetic retinopathy (DR) in Asians and facilitate the identification of new therapeutic targets through untargeted metabolomics. To determine the difference
